We found four genes (i.e., CYTOR, CXCL13, VCAM1, and TIMD4) explicitly expressed in malignant T cells, which may be potential novel markers for SPTCL. This evidence concerns the gene CXCL13 and subcutaneous panniculitis-like T-cell lymphoma.